K
Kevin Mills
Researcher at UCL Institute of Child Health
Publications - 133
Citations - 4465
Kevin Mills is an academic researcher from UCL Institute of Child Health. The author has contributed to research in topics: Fabry disease & Medicine. The author has an hindex of 35, co-authored 114 publications receiving 3268 citations. Previous affiliations of Kevin Mills include University College London & Great Ormond Street Hospital.
Papers
More filters
Journal ArticleDOI
Ageing, age-related diseases and oxidative stress: What to do next?
TL;DR: It is proposed that oxidized vitamin E metabolites may be used to accurately monitor individual functional antioxidant level, which might serve as promising key solutions for future elucidating the impact of oxidative stress on ageing and age-related diseases.
Journal ArticleDOI
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
Amanda Heslegrave,Wendy E. Heywood,Ross W. Paterson,Nadia K. Magdalinou,Johan Svensson,Per Johansson,Annika Öhrfelt,Kaj Blennow,John Hardy,Jonathan M. Schott,Kevin Mills,Henrik Zetterberg,Henrik Zetterberg +12 more
TL;DR: A mass spectrometry method using selected reaction monitoring for the presence of a TREM2 peptide is developed, which can be used to quantify levels of sTREM2 in CSF, and correlate with markers of neurodegeneration.
Journal ArticleDOI
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
Catherine J. Reynolds,Corinna Pade,Joseph Gibbons,Diana Munoz Sandoval,George Joy,Nasim Forooghi,Charlotte Manisty,James C. Moon,Rosemary J. Boyton,Hakam Abbass,Aderonke Abiodun,Mashael Alfarih,Zoe Alldis,Daniel M. Altmann,Oliver E. Amin,Mervyn Andiapen,Jessica Artico,João B Augusto,Georgina L Baca,Sasha N. L. Bailey,Anish N Bhuva,Alex Boulter,Ruth Bowles,Olivia V Bracken,Ben O’Brien,Tim Brooks,Natalie Bullock,David Butler,Gabriella Captur,Olivia Carr,Nicola Champion,Carmen Chan,Aneesh Chandran,Tom Coleman,Jorge Couto de Sousa,Xose Couto-Parada,Eleanor Cross,Teresa Cutino-Moguel,Silvia D'Arcangelo,Rhodri H Davies,Brooke Douglas,Cecilia Di Genova,Keenan Dieobi-Anene,Mariana O. Diniz,Ana Gabriela Aguilar Ellis,Karen Feehan,M. Finlay,Marianna Fontana,Sasha Francis,David Gillespie,Derek W. Gilroy,Matt Hamblin,Gabriella Harker,Georgia C. Hemingway,Jacqueline Hewson,Wendy E. Heywood,Lauren M. Hickling,Bethany Hicks,Aroon D. Hingorani,Lee Howes,Ivie Itua,Victor Jardim,Wing-Yiu Jason Lee,Melanie Jensen,Jessica Jones,Meleri Jones,V. S. Kapil,Caoimhe Kelly,H. Kurdi,Jonathan Lambourne,Kai-Min Lin,Siyi Liu,Aaron Lloyd,Sarah Louth,Mala K. Maini,Vineela Mandadapu,Áine McKnight,Katia Menacho,C. Mfuko,Kevin Mills,Sebastian Millward,Oliver Mitchelmore,Christopher William Moon,Sam M. Murray,Mahdad Noursadeghi,Ashley Otter,Susana Palma,Ruth Parker,Kush Patel,Mihaela Pawarova,Steffen E. Petersen,Brian Piniera,Franziska P Pieper,Lisa Rannigan,Alicja Rapala,Amy Richards,Matthew Robathan,Joshua Rosenheim,Cathy Rowe,M Royds,Jane Sackville West,Genine Sambile,Nathalie Schmidt,Hannah Selman,Amanda Semper,Andreas Seraphim,Mihaela Simion,Angelique Smit,Michelle Sugimoto,Leo Swadling,Stephen Taylor,Nigel J. Temperton,Stephen Thomas,George Douglas Thornton,Thomas A. Treibel,Arthur Tucker,A. Varghese,Jessry Veerapen,Mohit Vijayakumar,Time Warner,Sophie Welch,Hannah White,Theresa Wodehouse,Lucinda Wynne,Dan Zahedi,Benjamin M. Chain +125 more
TL;DR: B and T cell immunity against previous variants of concern was enhanced in triple vaccinated individuals, but magnitude of T and B cell responses against B.1.1 .1.529 spike protein was reduced.
Journal ArticleDOI
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.
Stephen Mullin,Stephen Mullin,Laura Smith,Katherine Lee,Gayle D’Souza,Philip Woodgate,Josh Elflein,Jenny Hällqvist,Marco Toffoli,Adam Streeter,Joanne Hosking,Wendy E. Heywood,Rajeshree Khengar,Philip Campbell,Jason Hehir,Sarah Cable,Kevin Mills,Henrik Zetterberg,Patricia Limousin,Vincenzo Libri,Thomas Foltynie,Anthony H.V. Schapira +21 more
TL;DR: Ambroxol therapy has potential for study as a neuroprotective compound for the treatment of patients with Parkinson disease both with and without glucocerebrosidase gene mutations.
Journal ArticleDOI
Clinical phenotype of desmosterolosis
David R. FitzPatrick,Jean W. Keeling,Margaret J. Evans,Alex E. Kan,Jeanne E. Bell,Mary Porteous,Kevin Mills,Robin M. Winter,Peter E. Clayton +8 more
TL;DR: The biochemical phenotype in this infant is highly suggestive of a novel inborn error of cholesterol biosynthesis caused by an autosomal recessive deficiency of 3betahydroxysterol-delta24-reductase.